Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

OBJECTIVE: To evaluate the efficacy and safety of canagliflozin, a sodium glucose cotransporter 2 inhibitor, compared with sitagliptin in subjects with type 2 diabetes inadequately controlled with metformin plus sulfonylurea. RESEARCH DESIGN AND METHODS: In this 52-week, randomized, double-blind, ac...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Schernthaner, Guntram, Gross, Jorge L., Rosenstock, Julio, Guarisco, Michael, Fu, Min, Yee, Jacqueline, Kawaguchi, Masato, Canovatchel, William, Meininger, Gary
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2013
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747923/
https://ncbi.nlm.nih.gov/pubmed/23564919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2491
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak